×
About 73,590 results

ALLMedicine™ Cirrhosis Center

Research & Reviews  35,335 results

Characterization of Essential Domains in HSD17B13 for Cellular Localization and Enzymat...
https://doi.org/10.1194/jlr.RA120000907
Journal of Lipid Research; Ma Y, Karki S et. al.

Sep 25th, 2020 - Recently, human genetic studies identified an association of single-nucleotide polymorphisms (SNPs) in the HSD17B13 (17-beta hydroxysteroid dehydrogenase 13) gene with alcoholic and nonalcoholic fatty liver disease (NAFLD) development. Mutant HSD1...

Impact of liver cirrhosis on the difficulty of minimally-invasive liver resections: a 1...
https://doi.org/10.1007/s00464-020-08018-0
Surgical Endoscopy; Goh BKP, Syn N et. al.

Sep 25th, 2020 - The impact of liver cirrhosis on the difficulty of minimal invasive liver resection (MILR) remains controversial and current difficulty scoring systems do not take in to account the presence of cirrhosis as a significant factor in determining the ...

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis a...
https://doi.org/10.3350/cmh.2020.0228
Clinical and Molecular Hepatology; Kwo P, Dronamraju D

Sep 24th, 2020 - More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis.|2020|Kwo P,Dronamraju D,|

A global investment framework for the elimination of hepatitis B.
https://doi.org/10.1016/j.jhep.2020.09.013
Journal of Hepatology; Howell J, Pedrana A et. al.

Sep 24th, 2020 - More than 292 million people are living with hepatitis B worldwide and are at risk of death from liver cirrhosis and liver cancer. The World Health Organization (WHO) has set global targets for the elimination of viral hepatitis as a public health...

In the era of direct-acting antivirals, liver transplant delisting due to clinical impr...
https://doi.org/10.1016/j.cgh.2020.09.033
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association; Bittermann T, Reddy KR

Sep 24th, 2020 - Studies have suggested marked increases in transplant delisting due to clinical improvement for patients with hepatitis C virus (HCV) associated cirrhosis in the era of direct acting antivirals (DAAs). This study provides a 'real world' assessment...

see more →

Guidelines  103 results

ACR Appropriateness Criteria® Chronic Liver Disease.
https://doi.org/10.1016/j.jacr.2020.01.023
Journal of the American College of Radiology : JACR; , Bashir MR et. al.

May 5th, 2020 - The liver fibrosis stage is the most important clinical determinate of morbidity and mortality in patients with chronic liver diseases. With newer therapies, liver fibrosis can be stabilized and possibly reversed, thus accurate diagnosis and stagi...

ACR Appropriateness Criteria® Radiologic Management of Gastric Varices.
https://doi.org/10.1016/j.jacr.2020.01.017
Journal of the American College of Radiology : JACR; , Kim CY et. al.

May 5th, 2020 - Hemorrhage, resulting from gastric varies, can be challenging to treat, given the various precipitating etiologies. A wide variety of treatment options exist for managing the diverse range of the underlying disease processes. While cirrhosis is th...

Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.
https://doi.org/10.1016/j.clinre.2020.03.014
Clinics and Research in Hepatology and Gastroenterology; Abergel A, Gasperment M et. al.

Apr 21st, 2020 - Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.|2020|Abergel A,Gasperment M,Nery FG,Buchard B,Lebreton A,|

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160350
Clinical and Molecular Hepatology;

Jan 10th, 2020 - KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.|2020| ,|

Chinese guidelines on management of hepatic encephalopathy in cirrhosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767982
World Journal of Gastroenterology; Xu XY, Ding HG et. al.

Oct 2nd, 2019 - The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and...

see more →

Drugs  783 results see all →

Clinicaltrials.gov  36,463 results

Characterization of Essential Domains in HSD17B13 for Cellular Localization and Enzymat...
https://doi.org/10.1194/jlr.RA120000907
Journal of Lipid Research; Ma Y, Karki S et. al.

Sep 25th, 2020 - Recently, human genetic studies identified an association of single-nucleotide polymorphisms (SNPs) in the HSD17B13 (17-beta hydroxysteroid dehydrogenase 13) gene with alcoholic and nonalcoholic fatty liver disease (NAFLD) development. Mutant HSD1...

Impact of liver cirrhosis on the difficulty of minimally-invasive liver resections: a 1...
https://doi.org/10.1007/s00464-020-08018-0
Surgical Endoscopy; Goh BKP, Syn N et. al.

Sep 25th, 2020 - The impact of liver cirrhosis on the difficulty of minimal invasive liver resection (MILR) remains controversial and current difficulty scoring systems do not take in to account the presence of cirrhosis as a significant factor in determining the ...

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis a...
https://doi.org/10.3350/cmh.2020.0228
Clinical and Molecular Hepatology; Kwo P, Dronamraju D

Sep 24th, 2020 - More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis.|2020|Kwo P,Dronamraju D,|

A global investment framework for the elimination of hepatitis B.
https://doi.org/10.1016/j.jhep.2020.09.013
Journal of Hepatology; Howell J, Pedrana A et. al.

Sep 24th, 2020 - More than 292 million people are living with hepatitis B worldwide and are at risk of death from liver cirrhosis and liver cancer. The World Health Organization (WHO) has set global targets for the elimination of viral hepatitis as a public health...

Aminocaproic acid - aminocaproic acid solution-TruPharma LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afffd309-3819-07c6-e053-2995a90a948b

Sep 24th, 2020 - Aminocaproic acid is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations, transfusion of appropriate blood products and other emergency measures may be required. Fibrinolytic bleeding may freque...

see more →

News  815 results

Noninvasive fibrosis scores not sensitive in people with fatty liver disease and T2D
https://www.mdedge.com/gihepnews/article/220037/hepatology/noninvasive-fibrosis-scores-not-sensitive-people-fatty-liver
Jennie Smith, MDedge News

Apr 1st, 2020 - Noninvasive fibrosis scores, which are widely used to predict advanced fibrosis in people with nonalcoholic fatty liver disease (NAFLD), do not do a good job of picking up advanced fibrosis in patients with underlying diabetes, according to a new.

Liver cancer risk reduced by aspirin in chronic viral hepatitis
https://www.mdedge.com/gihepnews/article/219015/gastroenterology/liver-cancer-risk-reduced-aspirin-chronic-viral-hepatitis/page/0/1?channel=346

Mar 13th, 2020 - Limitations of the Study The current study findings are not new, but this is the best-designed study to date, commented Flemming. Still, there were a number of limitations, she noted.

Belapectin misses endpoints in NASH trial
https://www.mdedge.com/gihepnews/article/218838/hepatology/belapectin-misses-endpoints-nash-trial?channel=346
Amy Karon, MDedge News

Mar 11th, 2020 - For patients with nonalcoholic steatohepatitis (NASH) with cirrhosis and portal hypertension, belapectin therapy was safe but did not significantly improve fibrosis or hepatic venous pressure gradient, compared with placebo, according to the resul.

Experts recommend testing U.S. adults ages 18-79 for hep C
https://www.reuters.com/article/us-health-hepatitisc-screening/experts-recommend-testing-u-s-adults-ages-18-79-for-hep-c-idUSKBN20P2HS

Mar 2nd, 2020 - (Reuters Health) - With improved effectiveness of hepatitis C treatments, it’s worthwhile to screen U.S. adults for the virus, an expert panel says. The recommendations from the U.S. Preventive Services Task Force (USPSTF), published in JAMA, come...

Expert: Eliminating HCV ‘sounds ambitious, but I think it’s possible’
https://www.mdedge.com/internalmedicine/article/218145/infectious-diseases/expert-eliminating-hcv-sounds-ambitious-i-think/page/0/1?channel=39313

Mar 1st, 2020 - Weighing treatment options The most common oral regimens for chronic HCV include sofosbuvir/ledipasvir, sofosbuvir/velpatasvir, and glecaprevir/pibrentasvir. They achieve cure in 93%-100% of cases.

see more →

Patient Education  91 results see all →